Published: 5 March 2026

Publications

Quarterly summary of recent safety communications

Published: 5 March 2026
Prescriber Update 47(1): 4
March 2026

The table below is a summary of recent safety communications for healthcare professionals and consumers. Click on a specific topic to go to the communication.

Date	Communication	Topic
09/02/2026	Dear Healthcare Professional Letter	Alecensa (alectinib) new adverse reaction of severe hypertriglyceridaemia (PDF, 2 pages, 145 KB)
02/02/2026	Dear Healthcare Professional Letter	Zypine ODT (Olanzapine) 10 mg Orodispersible Tablets – Alternative Registered Foils (PDF, 2 pages, 410 KB)
26/01/2026	Monitoring	Glucagon-like peptide-1 receptor agonists (dulaglutide, liraglutide, semaglutide, tirzepatide) and acute persistent visual loss
16/01/2026	Dear Healthcare Professional Letter	Columvi (glofitamab): New important identified risk of haemophagocytic lymphohistiocytosis (PDF, 3 pages, 145 KB)
15/12/2025	Monitoring	Atomoxetine and the possible risk of gynaecomastia
28/11/2025	Alert	Recall of FreeStyle Libre 3 Plus CGM sensors (some batches only)
20/11/2025	Dear Healthcare Professional Letter	Codeine Phosphate Tablets (Noumed) 15 mg, 30 mg and 60 mg - Overlabelling of cartons and blister packs due to stock shortages / out of stock (PDF, 2 pages, 594 KB)

Note that sponsors write Dear Healthcare Professional Letters and distribute them to relevant healthcare professionals. Medsafe publishes copies of these letters on the Medsafe website.